| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102076344A Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070582A 2, 3-dihydroxy cinnamomum lactone derivative and application thereof |
| 05/25/2011 | CN102070558A New crystal form of febuxostat and preparation method thereof |
| 05/25/2011 | CN102068696A Freeze-dried powder injection with recombinant human tumor necrosis factor receptor (TNFR)-Fc fusion protein |
| 05/25/2011 | CN102068688A Application of mechno-growth factor and E peptide thereof to preparation of medicaments and materials for treating osteoporosis or bone defect |
| 05/25/2011 | CN102068596A Chinese medicine for treatment of gout |
| 05/25/2011 | CN102068582A Formula of traditional Chinese medicine for treating femoral head necrosis |
| 05/25/2011 | CN102068556A Traditional Chinese medicine for treatment of gout |
| 05/25/2011 | CN102068554A Oral medicament special for treating osteoproliferation |
| 05/25/2011 | CN102068534A Chinese medicinal composition for relaxing tendons and activating collaterals and preparation method thereof |
| 05/25/2011 | CN102068524A Medicated wine for treating rheumatoid disease and preparation method thereof |
| 05/25/2011 | CN102068517A Formula of traditional Chinese medicine for treating cervical spondylosis |
| 05/25/2011 | CN102068511A External medicament for treating lumbar vertebral disc protrusion |
| 05/25/2011 | CN102068505A Quality control method for Chinese medicinal preparation muscle-stretching pain-relieving tablets |
| 05/25/2011 | CN102068495A Capsules for treating cervical spondylosis |
| 05/25/2011 | CN102068493A Chinese medicinal plaster |
| 05/25/2011 | CN102068485A Preparation and application of high-efficiency and low-toxicity effective fraction for suppressing angiogenesis in silktree albizzia bark |
| 05/25/2011 | CN102068481A Preparation and application of low-toxicity effective fraction for suppressing angiogenesis in cowherb seed |
| 05/25/2011 | CN102068474A Capparis spinosa fruit gel ointment, production method thereof, and application thereof to antirheumatic medicaments |
| 05/25/2011 | CN102068457A Application of ascites tumor cell in preparing bone cancer pain model |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068434A Application of 4-(cyclohexyl)-aminoquinazoline compounds |
| 05/25/2011 | CN102068427A Use of compound |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN102068396A Acne cream |
| 05/25/2011 | CN101757272B Traditional Chinese medicine capsule for treating osteoporosis and degenerative osteoarthritis |
| 05/25/2011 | CN101716265B Traditional Chinese medicine combination for treating lumer disc hyperosteogeny |
| 05/25/2011 | CN101703646B Externally applied Chinese medicine composition for treating hyperosteogeny |
| 05/25/2011 | CN101703645B Chinese medicinal composition for treating cervical vertebra hyperosteogeny |
| 05/25/2011 | CN101703644B External Chinese medicine composition for treating hyperosteogeny |
| 05/25/2011 | CN101612293B Traditional Chinese medicine composition for treating joint type psoriasis |
| 05/25/2011 | CN101502603B Chinese medicine for treating bone fracture |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101461879B Plaster for treating neck, spine, protrusion of lumbar vertebral disc, hyperosteogeny, arthralgia and myalgia |
| 05/25/2011 | CN101361972B Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 05/25/2011 | CN101347487B Chinese medicine external-use decoction for dispelling wind |
| 05/25/2011 | CN101321528B 3 , llb-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 05/25/2011 | CN101297946B Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof |
| 05/25/2011 | CN101250206B Effective part containing cyaniding 3-O-glucoside as well as preparation method and use thereof |
| 05/25/2011 | CN101249278B Bone induction material and preparation method and application thereof |
| 05/25/2011 | CN101227926B Use of composition in preparing medicine for treating osteoarthritis |
| 05/25/2011 | CN101152262B Anti-gout novel medical preparation |
| 05/25/2011 | CN101129720B Compound medicament for treating ankylosing spondylitis |
| 05/25/2011 | CN101028354B Detection method of siegesbeckia orientalis tablets |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2479737C Nanoparticulate compositions of map kinase inhibitors |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2468719C Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein |
| 05/19/2011 | WO2011059388A1 Oxazolo[4,5-c]pyridine substituted pyrazine |
| 05/19/2011 | WO2011059326A2 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058993A1 Method for screening for novel bone resorption inhibitor |
| 05/19/2011 | WO2011058943A1 Pharmaceutical composition formed from combining compound having mch r1 antagonist activity and compound having npy y5 antagonist activity |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058443A1 Method and device to induce collagen biomineralisation |
| 05/19/2011 | WO2011057757A1 New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives |
| 05/19/2011 | WO2011034274A3 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol |
| 05/19/2011 | WO2011008052A3 Composition for the prevention or treatment of bone diseases comprising colforsin daropate |
| 05/19/2011 | WO2010151740A4 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 05/19/2011 | WO2010151338A3 Myostatin inhibitor enhancement of musculoskeletal repair |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118354 Cyclohexenyl modulators of chemokine receptor activity |
| 05/19/2011 | US20110118326 Androgen Receptor Modulator and Uses Thereof |
| 05/19/2011 | US20110118325 Rel inhibitors and methods of use thereof |
| 05/19/2011 | US20110118281 Compounds for inflammation and immune-related uses |
| 05/19/2011 | US20110118275 OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE |
| 05/19/2011 | US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
| 05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
| 05/19/2011 | US20110118243 Anti-inflammatory drug delivery system |
| 05/19/2011 | US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 05/19/2011 | US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof |
| 05/19/2011 | US20110118211 Novel glucokinase activators and methods of using same |
| 05/19/2011 | US20110118207 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 05/19/2011 | US20110117207 Use of eggshell membrane formulations to alleviate joint pain |
| 05/19/2011 | US20110117197 Sustained-release drug carrier composition |
| 05/19/2011 | US20110117171 Implantable bone graft materials |
| 05/19/2011 | US20110117168 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117167 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117166 Implantable bone graft materials |
| 05/19/2011 | US20110117136 Dehydroepiandrosterone production promoter and use thereof |
| 05/19/2011 | US20110117082 Soluble Tumor Necrosis Factor Receptor Mutant |
| 05/19/2011 | US20110117081 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 05/19/2011 | US20110117073 Protein Kinase Conjugates and Inhibitors |
| 05/19/2011 | US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
| 05/19/2011 | US20110117021 Fully human anti-vap-1 monoclonal antibodies |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322638A1 AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| 05/18/2011 | EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy |